Nordmark Arzneimittel GmbH & Co. KG - search results

United States - English - NLM (National Library of Medicine)

pancreaze- pancrelipase capsule, delayed release

janssen pharmaceuticals, inc. - pancrelipase lipase (unii: 8myc33932o) (pancrelipase lipase - unii:8myc33932o), pancrelipase amylase (unii: yoj58o116e) (pancrelipase amylase - unii:yoj58o116e), pancrelipase protease (unii: 3560d81v50) (pancrelipase protease - unii:3560d81v50) - pancrelipase lipase 4200 [usp'u] - pancreaze (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. none. teratogenic effects pregnancy category c: animal reproduction studies have not been conducted with pancrelipase. it is not known whether pancrelipase can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. pancreaze should be given to a pregnant woman only if clearly needed. the risk and benefit of pancrelipase should be considered in the context of the need to provide adequate nutritional support to a pregnant woman with exocrine pancreatic insufficiency. adequate caloric intake during pregnancy is important for normal maternal weight gain and fetal growth. reduced maternal weight gain and malnutrition can be associated with adverse pregnancy outcomes. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when pancreaze is administered to a nursing

Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

kalium-nordmark 1,56 g kalium / 2,5 g citrat brausetabletten

Singapore - English - HSA (Health Sciences Authority)

iruxol mono ointment

smith & nephew pte limited - associated proteases; clostridiopeptidase a - ointment - 0.24 u/g - associated proteases 0.24 u/g; clostridiopeptidase a 1.2 u/g